Your browser doesn't support javascript.
loading
Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes.
Zanders, M M J; Haak, H R; van Herk-Sukel, M P P; Herings, R M C; van de Poll-Franse, L V; Johnson, J A.
Afiliação
  • Zanders MMJ; Netherlands Comprehensive Cancer Organisation,, P.O. Box 231, 5600 AE Eindhoven, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Eindhoven/Veldhoven, P.O. Box 7777. 5500 MB Veldhoven, The Netherlands. Electronic address: m.zanders@iknl.nl.
  • Haak HR; Department of Internal Medicine, Máxima Medical Centre, Eindhoven/Veldhoven, P.O. Box 7777. 5500 MB Veldhoven, The Netherlands; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, P.O. Box 5800, 6229 HX, Maastricht, The Netherlands; Maastric
  • van Herk-Sukel MPP; PHARMO Institute for Drug Outcomes Research, Van Deventerlaan 30-40, 3528 AE, Utrecht, The Netherlands.
  • Herings RMC; PHARMO Institute for Drug Outcomes Research, Van Deventerlaan 30-40, 3528 AE, Utrecht, The Netherlands.
  • van de Poll-Franse LV; Netherlands Comprehensive Cancer Organisation,, P.O. Box 231, 5600 AE Eindhoven, The Netherlands; Center of Research on Psychology in Somatic Diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, P.O. Box 90153, 5000 LE, Tilburg, The Netherlands; Division of Psychosoci
  • Johnson JA; School of Public Health, University of Alberta, 87 Ave, 11405 Edmonton, AB T6G 1C9, Canada.
Diabetes Metab ; 44(1): 22-29, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29066209

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article